NovaMea

About NovaMea

NovaMea SA is a Swiss startup focused on producing green hydrogen at a low cost using just water and electricity. The company operates in the renewable energy market, specifically targeting the hydrogen production sector. NovaMea's innovative approach leverages advanced membrane technology to split water into hydrogen and oxygen efficiently. This technology is based on over a decade of research from the Swiss Federal Institute of Technology Lausanne (EPFL), particularly from the lab of Prof. Xile Hu, who is also a co-founder and the first Chairman of the Board of NovaMea.

NovaMea serves a diverse range of clients, including industrial companies looking to reduce their carbon footprint, energy firms seeking sustainable energy solutions, and governmental bodies focused on environmental initiatives. The company’s business model revolves around licensing its proprietary technology and selling the membranes and catalysts required for hydrogen production. This dual approach allows NovaMea to generate revenue through both direct sales and ongoing licensing fees.

The company has recently made significant strides, including securing financial support from InnoSuisse, the Swiss Innovation Agency, to scale up the synthesis of its innovative polymers. Additionally, NovaMea has signed a license agreement with EPFL, granting it exclusive rights to four breakthrough technologies in anion exchange membranes, ionomers, and water-splitting catalysts. This agreement also gives EPFL an option to acquire shares in NovaMea, indicating strong institutional support and confidence in the startup's potential.

NovaMea's leadership team has been strengthened with the hiring of Dr. Xingyu Wu as Director of Research and Development. Dr. Wu, an expert in membrane technology with a PhD from EPFL, is expected to drive further innovation and development within the company.